Metropolitan Digital

Men's Weekly


.

Could pressure for COVID-19 drugs lead the FDA to lower its standards?

  • Written by Leigh Turner, Associate Professor, University of Minnesota Center for Bioethics, School of Public Health, & College of Pharmacy, University of Minnesota
Could pressure for COVID-19 drugs lead the FDA to lower its standards?Laboratories around the world are working round the clock to find treatments or a vaccine for COVID-19.Getty Images / Kena Betancur

Given the death, suffering, social disruption and economic devastation caused by COVID-19, there is an urgent need to quickly develop therapies to treat this disease and prevent the spread of the virus.

But the Food and...

Read more: Could pressure for COVID-19 drugs lead the FDA to lower its standards?

More Articles ...

  1. The stay-at-home slowdown – how the pandemic upended our perception of time
  2. Cuba's clean rivers show the benefits of reducing nutrient pollution
  3. How the US government sold the Peace Corps to the American public
  4. Indian philosophy helps us see clearly, act wisely in an interconnected world
  5. Are religious communities reviving the revival? In the US, outdoor worship has a long tradition
  6. Militias evaluate beliefs, action as president threatens soldiers in the streets
  7. What – or who – is antifa?
  8. COVID-19's deadliness for men is revealing why researchers should have been studying immune system sex differences years ago
  9. Coronavirus deaths and those of George Floyd and Ahmaud Arbery have something in common: Racism
  10. States are making it harder to sue nursing homes over the coronavirus, and that’s a bad idea
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more